Can I Buy Johnson & Johnson Shares in India?

Yes, Johnson & Johnson shares can be bought in India by opening an international trading account with Groww.

How to Buy Johnson & Johnson Shares in India?

One can easily invest in Johnson & Johnson shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Johnson & Johnson shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Johnson & Johnson.

What is the Share Price of Johnson & Johnson?

The share price of Johnson & Johnson is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Johnson & Johnson share price is $146.97 as of 26 May ‘24

What is the Market Cap of Johnson & Johnson?

The Johnson & Johnson market cap is $353.70B as of 26 May ‘24

What is the PE and PB ratio of Johnson & Johnson?

The PE and PB ratio of Johnson & Johnson is 9.2 and 5.1 as of 26 May ‘24

Johnson & Johnson Share Price, JNJ Stock Price Quote Today

<img alt="Johnson &amp; Johnson" srcSet="https://assets-netstorage.groww.in/intl-stocks/logos/JNJ.png 1x, https://assets-netstorage.groww.in/intl-stocks/logos/JNJ.png 2x" src="png/jnj.png" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="companyLogo_companyImage__bT0On absolute-center uspp14Logo" loading="lazy"/>
Johnson & Johnson Healthcare 
$146.97
-2.73(1.82%) 1D
1D
1W
1M
1Y
3Y
5Y
Performance
Open PricePrev. CloseVolumeAvg. Volume
$149.53$149.709,520,5767,990,233
FundamentalsMarket Cap$353.70B
P/B Ratio5.1
P/E Ratio9.2
Enterprise Value$361.86B
Div. Yield3.31%
Book Value28.23
EPS(TTM)13.61
ROE47.10%
Understand Fundamentals
FUNDAMENTALS
It is financial information that is reported quarterly or annually.
Market Cap
Market cap or market capitalization is the total market value of all of a company's outstanding shares.
Div. Yield
The divided yield displayed as a percentage is the amount of money a company pays shareholders for owning a share of its stock divided by its current stock price
P/B Ratio
The price-to-book ratio is a company's current market price to its Book Value. Traditionally, any value under 1.0 is considered a good P/B value, indicating a potentially undervalued stock.
Book Value
The book value of a stock is theoretically the amount of money that would be paid to shareholders if the company was liquidated and paid off all of its liabilities.
P/E Ratio
The price-earnings ratio is a company's share price to the company's Earnings per Share. The ratio is used for evaluating companies and to find out whether they are overvalued or undervalued.
EPS(TTM)
Earnings per share (EPS) is a company's net profit divided by the number of common shares it has outstanding. EPS indicates how much money a company makes for each share of its stock, and is widely used metric to estimate corporate value
Enterprise Value
Enterprise Value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
ROE
Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholder's equity
About the CompanyJohnson and Johnson (J&J) is a multinational company, which manufactures and sells pharmaceutical products, medical devices and consumer packaged commodities. The company has more than 250 subsidiaries and operates in approximately 60 countries worldwide. Johnson and Johnson shares are traded on the New York Stock Exchange (NYSE) under the ticker symbol “JNJ”.
Some of its consumer commodities include baby care, skincare, and oral care products. Few of the most noteworthy products are Band-Aid, Clean and Clear face wash, Neutrogena skin care and beauty products, etc. The medical devices segment involves the production and sale of various products that are used in fields related to healthcare, such as orthopaedic, surgical and vision care. The pharmaceutical segment involves the development of medicines that are focused on treating infectious, metabolic and cardiovascular diseases. It also manufactures medicines for oncology and neuroscience divisions.
JNJ research facilities are located in various countries worldwide; some of them include Brazil, France, India, China, Canada and Japan. JNJ was founded in 1886 and started operations with a team of 14 employees. They manufactured household commodities and surgical supplies and sterile instruments that used to have a logo resembling the signature of one of the co-founders, James Wood Johnson. JNJ made history when it became the first company in the world to produce sterile surgical products like gauze and absorbent cotton.
In 1921, JNJ launched Johnson’s Baby Soap, and ten years later, it started manufacturing and selling the first prescription contractive gel under the name Ortho-Gynol. Some of the notable subsidiaries of JNJ include Janssen Pharmaceutica, Neutrogena, Biosense Webster, Janssen Biotech, Ortho-McNeil Pharmaceutical, Animas Corporation and Advanced Sterilization Products Services, Inc.
Since its inception, JNJ has acquired more than 40 companies out of which 9 were private equity firms. In 1998, it acquired DePuy, which further strengthened its medical devices segment. In 2012, JNJ announced the acquisition of Synthes for an estimated $19.7 billion. Two years later, in 2014, Alios BioPharma was acquired by JNJ for $1.75 billion. It completed its largest acquisition in 2017 when it acquired Actelion Pharmaceuticals Ltd. for approximately $30 billion. JNJ has made acquisitions in more than ten states in America and over five countries worldwide.
In 2019, JNJ announced that one of its subsidiaries, Ethicon, had reached an agreement to acquire Auris Health, Inc. The acquisition was completed for $3.4 billion in cash and involved $2.3 billion worth of contingent payments based on future performance. In August 2020, it announced that it would be acquiring Momenta Pharmaceuticals for approximately 6.5 million. In 2014, JNJ disclosed its largest sale, when it sold its Ortho-Clinical Diagnostics to the Carlyle Group for over $4 billion.
In 2020, JNJ received the Best Leadership Teams 2020 award. In the same year, JNJ ranked 34th on the Forbes’ list of the world’s 2,000 largest public companies. It also occupied the 35th spot on the list of the Fortune 500 companies in 2020.;
OrganisationJohnson & Johnson
IndustryDrug Manufacturers—General
HeadQuartersNew Brunswick, NJ
Company Financials
*All values are in Million $
No Graph Data To Display
Quarterly
Yearly
See Details
Similar StocksCOMPANYMARKET PRICECLOSE PRICEMARKET CAP

Invest the way you want

Join millions of Indians who trust and love Groww

Explore Products

Vaishnavi Tech Park, 3rd & 4th Floor
Sarjapur Main Road, Bellandur
Bengaluru – 560103
Contact Us
PRODUCTS
StocksFutures & OptionsIPOMutual FundsNFOCreditBill Payments
GROWW
About UsPricingBlogMedia & PressCareersHelp and SupportTrust and Safety
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemapIncome Tax Calculator
ⓒ 2016-2024 Groww. All rights reserved, Built with ♥in India

Open Price	Prev. Close	Volume	Avg. Volume
$149.53	$149.70	9,520,576	7,990,233

Market Cap	$353.70B
P/B Ratio	5.1
P/E Ratio	9.2
Enterprise Value	$361.86B

Organisation	Johnson & Johnson
Industry	Drug Manufacturers—General
HeadQuarters	New Brunswick, NJ